Effects of pulmonary rehabilitation in children with primary immunodeficiency
Investigation of the Effects of Pulmonary Rehabilitation on Exercise Capacity, Muscle Oxygenation and Physical Activity Level in Children With Primary Immunodeficiency
This study tests if a special exercise program can help children with primary immunodeficiency breathe better and be more active.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 6 Years to 18 Years |
| Sex | All |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT06092528 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of pulmonary rehabilitation on children aged 6-18 years diagnosed with primary immunodeficiency (PID). It focuses on various interventions including inspiratory muscle training, aerobic exercise for upper and lower extremities, resistance training, and thoracic expansion exercises. The aim is to improve exercise capacity, muscle oxygenation, and overall physical activity levels in these patients, who often suffer from significant pulmonary complications. By addressing these issues, the study seeks to enhance the quality of life for children affected by PID.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6-18 years who have been diagnosed with primary immunodeficiency.
Not a fit: Patients experiencing acute pulmonary exacerbations or other serious systemic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the physical health and quality of life for children with primary immunodeficiency.
How similar studies have performed: While there is limited research specifically on pulmonary rehabilitation in PID, similar approaches in other chronic respiratory conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: -Patients aged 6-18 years with primary immunodeficiency Exclusion Criteria: * Acute pulmonary exacerbation, acute upper or lower respiratory tract infection * Serious neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions * Participating in a planned exercise program in the past three months * Cognitive impairment, which may cause difficulty understanding and following exercise test instructions
Where this trial is running
Ankara, Çankaya
- Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit — Ankara, Çankaya, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Betül Yoleri, Pt. MsC — Gazi University
- Study coordinator: Meral Boşnak Güçlü, Prof. Dr.
- Email: meralbosnak@gazi.edu.tr
- Phone: 03122162647
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.